Merit Medical Systems (MMSI) Cash from Financing Activities (2010 - 2026)

Merit Medical Systems has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$6.3 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$6.3 million, down 190.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 107.86% YoY), and the FY2025 annual result was $16.0 million, up 126.66% from the prior year.
• Cash from Financing Activities came in at -$6.3 million for Q1 2026 at Merit Medical Systems, down from $5.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $472.8 million in Q4 2023 to a low of -$54.6 million in Q3 2023.
• The 5-year median for Cash from Financing Activities is -$497000.0 (2023), against an average of $26.4 million.
• Across the five-year window, Cash from Financing Activities soared 8324.21% in 2023 and plunged 3522.33% in 2024, its largest moves.
• Merit Medical Systems' Cash from Financing Activities stood at -$5.7 million in 2022, then jumped by 8324.21% to $472.8 million in 2023, then slumped by 99.49% to $2.4 million in 2024, then jumped by 108.14% to $5.1 million in 2025, then slumped by 224.24% to -$6.3 million in 2026.
• The last three Cash from Financing Activities figures came in at -$6.3 million (Q1 2026), $5.1 million (Q4 2025), and -$365000.0 (Q3 2025), per Business Quant data.